Role of the M3 muscarinic acetylcholine receptor in β-cell function and glucose homeostasis

Diabetes, Obesity and Metabolism

Volumn 9, Issue SUPPL. 2, 2007, Pages 158-169

  Gautam, D ^a   Han, S J ^a,c   Duttaroy, A ^a,d   Mears, D ^b,e   Hamdan, F F ^a,f   Li, J H ^a   Cui, Y ^a   Jeon, J ^a   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Institute Pasteur Korea   (South Korea)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF CHILE   (Chile)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Acetylcholine; Conditional knockout mice; Cre lox technology; Glucose homeostasis; Glucose tolerance; Insulin release; Islets; Muscarinic acetylcholine receptors; Transgenic mice; Type 2 diabetes; cell function

Indexed keywords

ACETYLCHOLINE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 2; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; OXOTREMORINE M; INSULIN; MUSCARINIC AGENT;

CONFERENCE PAPER; FATTY ACID OXIDATION; GENE TARGETING; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ARTICLE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOMEOSTASIS; METABOLISM; MOUSE; MOUSE MUTANT; PANCREAS ISLET; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; RECEPTOR, MUSCARINIC M3;

EID: 35148844231     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00781.x     Document Type: Conference Paper

References (43)

1. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
2. Kahn SE. Clinical review 135: The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 4047-4058.
3. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001; 414: 821-827.
4. Satin LS, Kinard TA. Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: What messages do acetylcholine, glutamate, and GABA transmit? Endocrine 1998; 8: 213-223.
5. Ahren B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 2000; 43: 393-410.
6. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 2001; 22: 565-604.
7. Hoffman BB, Taylor P. The autonomic and somatic motor nervous systems. In: Hardman JG, Limbird LE eds. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 10th edn. New York: McGraw-Hill, 2001; 115-153.
8. Wess J. Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004; 44: 423-450.
9. Caulfield MP, Birdsall NJM. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50: 279-290.
10. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996; 10: 69-99.
11. Levey AI. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 1993; 52: 441-448.
12. Gomeza J, Shannon H, Kostenis E et al. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 1999; 96: 1692-1697.
13. 4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 1999; 96: 10483-10487.
14. 5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 2001; 98: 14096-14101.
15. Yamada M, Miyakawa T, Duttaroy A et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001; 410: 207-212.
16. 1 receptor to two mixed cation channels. Neuron 2002; 33: 615-624.
17. Henquin JC, Nenquin M. The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett 1988; 236: 89-92.
18. 3 muscarinic receptors. Am J Physiol 1995; 268: E336-E342.
19. Tang SH, Sharp GW. Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 1997; 46: 1419-1423.
20. Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ. Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 2000; 49: 392-398.
21. 3 muscarinic acetylcholine receptor-deficient mice. Diabetes 2004; 53: 1714-1720.
22. Zawalich WS, Zawalich KC, Tesz GJ et al. Effects of muscarinic receptor type 3 knockout on mouse islet secretory responses. Biochem Biophys Res Commun 2004; 315: 872-876.
23. 4 muscarinic acetylcholine receptor deficiency. Cell Metab 2006; 4: 363-375.
24. Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA. Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience 1994; 63: 207-221.
25. Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48: 531-565.
26. 3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 2006; 3: 449-461.
27. Doyle ME, Egan JM. Glucagon-like peptide-1. Recent Prog Horm Res 2001; 56: 377-399.
28. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, Hennighausen L. RIP-Cre revisited, evidence for impairments of pancreatic β-cell function. J Biol Chem 2006; 281: 2649-2653.
29. Niijima A. Neural mechanisms in the control of blood glucose concentration. J Nutr 1989; 119: 833-840.
30. Havel PJ, Parry SJ, Curry DL, Stern JS, Akpan JO, Gingerich RL. Autonomic nervous system mediation of the pancreatic polypeptide response to insulin-induced hypoglycemia in conscious rats. Endocrinology 1992; 130: 2225-2229.
31. Havel PJ, Parry SJ, Stern JS et al. Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. Metabolism 1994; 43: 860-866.
32. Postic C, Shiota M, Niswender KD et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274: 305-315.
33. Vasavada RC, Cavaliere C, D'Ercole AJ et al. Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem 1996; 271: 1200-1208.
34. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96: 329-339.
35. Maggio R, Barbier P, Fornai F, Corsini GU. Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J Biol Chem 1996; 271: 31055-31060.
36. 3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling. J Neurochem 1999; 72: 2404-2414.
37. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 2000; 26: 139-142.
38. Cui Y, Huang L, Elefteriou F et al. Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol 2004; 24: 258-269.
39. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 381-416.
40. Guo Y, Traurig M, Ma L et al. CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 2006; 55: 3625-3629.
41. Birdsall NJM, Lazareno S. Allosterism at muscarinic receptors: Ligands and mechanisms. Mini Rev Med Chem 2005; 5: 523-543.
42. Bockaert J, Fagni L, Dumuis A, Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 2004; 103: 203-221.
43. Berridge MJ, Dawson RM, Downes CP, Heslop JP, Irvine RF. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 1983; 212: 473-482.